Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Clinical Trials for
Viral Hemorrhagic Fever
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Not yet recruiting
Phase:
Early Phase 1
Intervention Type:
Drug, Other
Participants:
74
Start Date:
October 1, 2021
Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE): A Pilot Randomized Controlled Trial
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 3
Intervention Type:
Biological
Participants:
614
Start Date:
March 15, 2021
A Phase 3, Open-Label, Randomized Trial to Investigate the Immunogenicity and Safety of the Co-administration of a Subcutaneous Dengue Tetravalent Vaccine (Live, Attenuated) (TDV) and an Intramuscular Recombinant 9-Valent Human Papillomavirus (9vHPV) Vaccine in Subjects Aged ≥9 to <15 Years in an Endemic Country for Dengue
Search for trials
Clinical Trial
Status:
Not yet recruiting
Intervention Type:
Drug
Participants:
214
Start Date:
March 2021
A Pregnancy Registry to Evaluate the Safety of Dengue Vaccine Among Inadvertently Exposed Pregnant Women and Their Offsprings (DNG16)
Clinical Trial
Status:
Not yet recruiting
Participants:
8000
Start Date:
February 15, 2021
Serosurvey for Prevalence and Incidence of Lassa Virus Infection in Southern Mali
Clinical Trial
Status:
Recruiting
Phase:
Phase 1
Intervention Type:
Other
Participants:
80
Start Date:
February 15, 2021
Characterization of Skin Immunity to Aedes Aegypti Saliva in Dengue-Endemic Participants in Cambodia
Clinical Trial
Status:
Not yet recruiting
Participants:
350
Start Date:
February 15, 2021
Investigating the Sylvatic Transmission and Reservoir Potential of Zika, Dengue, and Chikungunya Viruses of Co-located Humans and Long-tailed Macaques of Thailand and Cambodia
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Biological, Other
Participants:
30
Start Date:
February 2021
A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Rift Valley Fever Virus (RVFV) Vaccine ChAdOx1 RVF Among Healthy Adult Volunteers in Uganda
Clinical Trial
Status:
Not yet recruiting
Intervention Type:
Biological
Participants:
500
Start Date:
February 2021
Dengvaxia US Pregnancy Registry: A Surveillance Study to Assess the Safety of Dengvaxia Among Exposed Pregnant Women and Their Offsprings (DNG00044)
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Drug
Participants:
25
Start Date:
February 1, 2021
An Open Study of the Safety and Pharmacokinetics of a Drug for the Emergency Prevention of Ebola Virus Disease Based on Humanized Monoclonal Antibodies
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Biological
Participants:
10
Start Date:
February 2021
A Study to Evaluate the Safety and Efficacy of PV-001-DV in Combination With Infusion of PV-001-DC in Patients With Advanced Melanoma
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Combination Product, Biological, Drug
Participants:
360
Start Date:
February 2021
(Isotretinoin (13- Cis-Retinoic Acid) Versus Spike Protein Based Vaccine
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2/Phase 3
Intervention Type:
Drug
Participants:
294
Start Date:
January 25, 2021
High-Dose Ivermectin for Mild-to-Moderate COVID-19 - The (HD)IVACOV Trial
Showing 1-12 of 91
Next